AI Energy Inc., a development stage company, focuses on discovery and development of analgesic and anti-inflammatory products based on the proprietary MPL-TL (tripeptofen) compound. The company was formerly known as Molecular Pharmacology (USA), Ltd. and changed its name to AI Energy Inc. in April 2026. The company is based in Shanghai, China.